CY1108462T1 - Χρηση της αναστροζολης για τη θεραπευτικη αντιμετωπιση μετεμμηνοπαυσιακων γυναικων με καρκινο του μαστου σε πρωιμο σταδιο - Google Patents
Χρηση της αναστροζολης για τη θεραπευτικη αντιμετωπιση μετεμμηνοπαυσιακων γυναικων με καρκινο του μαστου σε πρωιμο σταδιοInfo
- Publication number
- CY1108462T1 CY1108462T1 CY20081101221T CY081101221T CY1108462T1 CY 1108462 T1 CY1108462 T1 CY 1108462T1 CY 20081101221 T CY20081101221 T CY 20081101221T CY 081101221 T CY081101221 T CY 081101221T CY 1108462 T1 CY1108462 T1 CY 1108462T1
- Authority
- CY
- Cyprus
- Prior art keywords
- breast cancer
- anastrozol
- women
- early stage
- treatment therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Chemical Treatment Of Metals (AREA)
Abstract
Η εφεύρεση παρέχει τη χρήση της αναστροζόλης, ή ενός φαρμακευτικώς αποδεκτού άλατος αυτής, στην παρασκευή ενός φαρμάκου για τη μείωση του ρυθμού υποτροπής του καρκίνου σε γυναίκα με καρκίνο του μαστού σε πρώιμο στάδιο. Η εφεύρεση παρέχει περαιτέρω τη χρήση της αναστροζόλης, ή ενός φαρμακευτικώς αποδεκτού άλατος αυτής, στην παρασκευή ενός φαρμάκου για τη μείωση του ρυθμού ενός νέου αμφοτερόπλευρου, πρωτοπαθούς όγκου σε μετεμμηνοπαυσιακή γυναίκα με καρκίνο του μαστού σε πρώιμο στάδιο.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0129457.8A GB0129457D0 (en) | 2001-12-10 | 2001-12-10 | Method of treatment |
| EP02783305A EP1455781B1 (en) | 2001-12-10 | 2002-12-06 | Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1108462T1 true CY1108462T1 (el) | 2014-04-09 |
Family
ID=9927290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081101221T CY1108462T1 (el) | 2001-12-10 | 2008-10-29 | Χρηση της αναστροζολης για τη θεραπευτικη αντιμετωπιση μετεμμηνοπαυσιακων γυναικων με καρκινο του μαστου σε πρωιμο σταδιο |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20050165081A1 (el) |
| EP (2) | EP1455781B1 (el) |
| JP (2) | JP5335173B2 (el) |
| KR (1) | KR100858946B1 (el) |
| CN (1) | CN100408036C (el) |
| AT (1) | ATE406160T1 (el) |
| AU (1) | AU2002347371B2 (el) |
| BR (1) | BR0214798A (el) |
| CA (1) | CA2468965C (el) |
| CO (1) | CO5590926A2 (el) |
| CY (1) | CY1108462T1 (el) |
| DE (1) | DE60228616D1 (el) |
| DK (1) | DK1455781T3 (el) |
| ES (1) | ES2303811T3 (el) |
| GB (1) | GB0129457D0 (el) |
| HK (1) | HK1069335A1 (el) |
| HU (1) | HUP0402023A3 (el) |
| IL (1) | IL162150A0 (el) |
| IS (1) | IS7300A (el) |
| MX (1) | MXPA04005394A (el) |
| NO (1) | NO20042912L (el) |
| NZ (1) | NZ533106A (el) |
| PL (1) | PL369411A1 (el) |
| PT (1) | PT1455781E (el) |
| RU (1) | RU2320339C2 (el) |
| SI (1) | SI1455781T1 (el) |
| UA (1) | UA79443C2 (el) |
| WO (1) | WO2003053438A1 (el) |
| ZA (1) | ZA200404260B (el) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0129457D0 (en) * | 2001-12-10 | 2002-01-30 | Astrazeneca Ab | Method of treatment |
| US8436029B2 (en) * | 2004-03-19 | 2013-05-07 | Transform Pharmaceuticals, Inc. | Pharmaceutical forms, and methods of making and using the same |
| WO2005117864A1 (en) * | 2004-05-28 | 2005-12-15 | Astrazeneca Ab | Combination product comprising anastrozole and a dual prenyl transferase inhibitor |
| CN100337625C (zh) * | 2004-08-30 | 2007-09-19 | 鲁南制药集团股份有限公司 | 阿那曲唑的分散片剂型 |
| CN1304054C (zh) * | 2004-12-29 | 2007-03-14 | 山东蓝金生物工程有限公司 | 一种缓慢释放的抗癌药物组合物 |
| GB0517674D0 (en) * | 2005-08-31 | 2005-10-05 | Astrazeneca Ab | Formulation |
| GB0517673D0 (en) * | 2005-08-31 | 2005-10-05 | Astrazeneca Ab | Formulation |
| WO2011130381A1 (en) * | 2010-04-13 | 2011-10-20 | Estrocept Diagnostics, Inc. | Diagnostic assays for breast cancer treatment and progression |
| US10201549B2 (en) | 2013-06-14 | 2019-02-12 | Professional Compounding Centers Of America (Pcca) | Testosterone combined with anastrozole injection solutions |
| CN103450099B (zh) * | 2013-09-06 | 2015-03-25 | 杭州华东医药集团新药研究院有限公司 | 阿那曲唑及其一水合物的新晶型、制备和用途 |
| RU2548722C1 (ru) * | 2013-12-06 | 2015-04-20 | Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" | Противоопухолевое лекарственное средство пролонгированного действия на основе противоопухолевого препарата, ингибитора синтеза эстрогенов - анастрозола |
| DE102014005513B4 (de) * | 2014-04-15 | 2018-03-15 | Sanoxsys Gmbh | Mittel zur Prävention und Therapie von Tumorerkrankungen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714013D0 (en) * | 1987-06-16 | 1987-07-22 | Ici Plc | (substituted-aralkyl)heterocyclic compounds |
| AR034142A1 (es) * | 2000-09-08 | 2004-02-04 | Sloan Kettering Inst Cancer | Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion |
| GB0129457D0 (en) * | 2001-12-10 | 2002-01-30 | Astrazeneca Ab | Method of treatment |
-
2001
- 2001-12-10 GB GBGB0129457.8A patent/GB0129457D0/en not_active Ceased
-
2002
- 2002-06-12 UA UA20040705521A patent/UA79443C2/uk unknown
- 2002-12-06 NZ NZ533106A patent/NZ533106A/xx not_active IP Right Cessation
- 2002-12-06 EP EP02783305A patent/EP1455781B1/en not_active Revoked
- 2002-12-06 BR BR0214798-0A patent/BR0214798A/pt not_active Application Discontinuation
- 2002-12-06 CN CNB02824544XA patent/CN100408036C/zh not_active Ceased
- 2002-12-06 AU AU2002347371A patent/AU2002347371B2/en not_active Revoked
- 2002-12-06 IL IL16215002A patent/IL162150A0/xx unknown
- 2002-12-06 DK DK02783305T patent/DK1455781T3/da active
- 2002-12-06 DE DE60228616T patent/DE60228616D1/de not_active Expired - Lifetime
- 2002-12-06 JP JP2003554195A patent/JP5335173B2/ja not_active Expired - Lifetime
- 2002-12-06 MX MXPA04005394A patent/MXPA04005394A/es active IP Right Grant
- 2002-12-06 EP EP08162209A patent/EP1997492A1/en not_active Withdrawn
- 2002-12-06 US US10/498,444 patent/US20050165081A1/en not_active Abandoned
- 2002-12-06 PT PT02783305T patent/PT1455781E/pt unknown
- 2002-12-06 HU HU0402023A patent/HUP0402023A3/hu not_active Application Discontinuation
- 2002-12-06 CA CA2468965A patent/CA2468965C/en not_active Expired - Fee Related
- 2002-12-06 SI SI200230746T patent/SI1455781T1/sl unknown
- 2002-12-06 ES ES02783305T patent/ES2303811T3/es not_active Expired - Lifetime
- 2002-12-06 AT AT02783305T patent/ATE406160T1/de active
- 2002-12-06 WO PCT/GB2002/005554 patent/WO2003053438A1/en active IP Right Grant
- 2002-12-06 KR KR1020047008806A patent/KR100858946B1/ko not_active IP Right Cessation
- 2002-12-06 RU RU2004121162/15A patent/RU2320339C2/ru not_active IP Right Cessation
- 2002-12-06 PL PL02369411A patent/PL369411A1/xx not_active Application Discontinuation
-
2004
- 2004-05-31 ZA ZA2004/04260A patent/ZA200404260B/en unknown
- 2004-06-04 IS IS7300A patent/IS7300A/is unknown
- 2004-07-08 CO CO04064979A patent/CO5590926A2/es not_active Application Discontinuation
- 2004-07-09 NO NO20042912A patent/NO20042912L/no not_active Application Discontinuation
-
2005
- 2005-03-08 HK HK05101996.7A patent/HK1069335A1/xx not_active IP Right Cessation
-
2008
- 2008-10-29 CY CY20081101221T patent/CY1108462T1/el unknown
-
2010
- 2010-09-06 JP JP2010199008A patent/JP2011016828A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108462T1 (el) | Χρηση της αναστροζολης για τη θεραπευτικη αντιμετωπιση μετεμμηνοπαυσιακων γυναικων με καρκινο του μαστου σε πρωιμο σταδιο | |
| CY1114040T1 (el) | Συνδυαστικη θεραπεια του καρκινου περιλαμβανουσα αναστολεις των egfr/her2 | |
| TR200102577T2 (tr) | Kanser Tedavisi için Casb616 Polipeptid ve Polinücleotidlerin kullanımı | |
| CY1106285T1 (el) | Χρηση αναστολεων της τυροσινης κινασης του egfr για τη θepαπεια του καρκινου του μαστου | |
| PA8588601A1 (es) | Administracion combinada de una indolinona junto a un agente quimioterapeutico para el tratamiento de enfermedades de proliferacion celular | |
| CY1105477T1 (el) | Αναστολεις τρανσφepασης φαρνεσυλ πρωτεϊνης για τη θepαπευτικη αντιμετωπιση του καρκινου του μαστου | |
| CY1111147T1 (el) | Διαμεμβρανικο αντιγονο λεκτινης τυπου c εκφραζομενο σε καρκινο στον προστατη ανθρωπου και χρησεις αυτου | |
| EA200101046A1 (ru) | Производные индигоидных бис-индолов | |
| NO20071585L (no) | Ny anvendelse av peptidforbindelser for behandling av benkreftsmerte, kjemoterapi- og nucleosidfremkalt smerte | |
| HUP0402656A2 (hu) | Sejtterápiás eljárás tumorok kezelésére | |
| HK1073601A1 (en) | Epothilone derivative for the treatment of hepatoma and other cancer diseases | |
| HK1068261A1 (en) | Combinations comprisinga selective cyclooxygenase-2 inhibitor | |
| HUP0301460A2 (hu) | Antiprogresztinek használata hormonfüggő betegségek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállításához | |
| AR039843A1 (es) | Tratamiento de padecimientos post-menopausicos en pacientes con cancer de mama | |
| HUP0203906A2 (en) | Aplidine treatment of cancers | |
| SV2002000179A (es) | Proceso para la preparacion de un compuesto para reducir el riesgo del cancer ref.x-13527-el | |
| NO20040973L (no) | Anvendelse av 4-pyridylmetylftalaziner for kreftbehandling | |
| DE69912477D1 (de) | Endokrintherapie für brustkrebs: kombinierte behandlung mit tamoxifen und alkyl-pcdfs | |
| ATE423780T1 (de) | Makrozyclen zur behandlung von krebserkrankungen | |
| UA87292C2 (ru) | Применение сирамезина для лечения злокачественных опухолей | |
| UY27768A1 (es) | 2-(2,6- diclorofenil)-diarilimidazoles | |
| ITMI20041822A1 (it) | "agente terapeutico utile per il trattamento di neoplasie plasmacellulari" | |
| MXPA04002407A (es) | Uso de 4-piridilmeetil-ftalazinas para el tratamiento de cancer. | |
| UA51221A (uk) | Спосіб лікування рецидивів раку шийки матки | |
| UA44635A (uk) | Спосіб імунотерапії раку молочної залози |